RGT-M001

N/A

Report date: 2024/04/28 16:18:11
First In Class

Base Information

Drug NameRGT-M001
Drug Alias NameRGT-M001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscriptional activator Myb inhibitors
TargetsTranscriptional activator Myb
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRgenta Therapeutics IncUniversity Of Massachusetts Medical School
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Massachusetts Medical School
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A